Cargando…

Predictors of participation in risk-based prostate cancer screening

BACKGROUND: Implementation of risk-based prostate cancer screening has been proposed as a means to reduce the harms of PSA screening. Little is known, however, about the factors influencing men’s decision to attend a prostate cancer screening based on a risk assessment. METHOD: We sent postal invita...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koitsalu, Marie, Eklund, Martin, Adolfsson, Jan, Sprangers, Mirjam A. G., Grönberg, Henrik, Brandberg, Yvonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039032/ https://www.ncbi.nlm.nih.gov/pubmed/29990335 http://dx.doi.org/10.1371/journal.pone.0200409

Ejemplares similares

The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects
por: Koitsalu, Marie, et al.
Publicado: (2021)

Effects of pre-notification, invitation length, questionnaire length and reminder on participation rate: a quasi-randomised controlled trial
por: Koitsalu, Marie, et al.
Publicado: (2018)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
por: Nordström, Tobias, et al.
Publicado: (2017)

External Validation of the Prostate Biopsy Collaborative Group Risk Calculator and the Rotterdam Prostate Cancer Risk Calculator in a Swedish Population-based Screening Cohort
por: Chandra Engel, Jan, et al.
Publicado: (2022)

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer
por: Björnebo, Lars, et al.
Publicado: (2020)

Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
por: Nordström, Tobias, et al.
Publicado: (2019)

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
por: Beckmann, Kerri, et al.
Publicado: (2019)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
por: Andersson, Joel, et al.
Publicado: (2022)

The future of breast cancer screening: what do participants in a breast cancer screening program think about automation using artificial intelligence?
por: Jonmarker, Olof, et al.
Publicado: (2019)

Patients' knowledge and perceived understanding – Associations with consenting to participate in cancer clinical trials
por: Brandberg, Yvonne, et al.
Publicado: (2015)

The economic burden of prostate cancer – a Swedish prevalence-based register study
por: Hao, Shuang, et al.
Publicado: (2020)

Why patients decline participation in an intervention to reduce re-hospitalization through patient activation: whom are we missing?
por: Flink, Maria, et al.
Publicado: (2019)

The impact of different prostate-specific antigen (PSA) testing intervals on Gleason score at diagnosis and the risk of experiencing false-positive biopsy recommendations: a population-based cohort study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

A Head-to-head Comparison of Prostate Cancer Diagnostic Strategies Using the Stockholm3 Test, Magnetic Resonance Imaging, and Swedish National Guidelines: Results from a Prospective Population-based Screening Study
por: Waldén, Mauritz, et al.
Publicado: (2022)

Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms
por: Nordström, Tobias, et al.
Publicado: (2021)

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
por: Khoshkar, Yashar, et al.
Publicado: (2021)

The Genetic Basis of Quality of Life in Healthy Swedish Women: A Candidate Gene Approach
por: Schoormans, Dounya, et al.
Publicado: (2015)

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women—A GWAS Study Using the iCOGS Custom Genotyping Array
por: Schoormans, Dounya, et al.
Publicado: (2015)

Using deep learning to detect patients at risk for prostate cancer despite benign biopsies
por: Liu, Bojing, et al.
Publicado: (2022)

Are Prostate Specific-Antigen (PSA) and age associated with the risk of ISUP Grade 1 prostate cancer? Results from 72 996 individual biopsy cores in 6 083 men from the Stockholm3 study
por: Palsdottir, Thorgerdur, et al.
Publicado: (2019)

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy
por: Ström, Peter, et al.
Publicado: (2020)

Transcriptome-wide prediction of prostate cancer gene expression from histopathology images using co-expression-based convolutional neural networks
por: Weitz, Philippe, et al.
Publicado: (2022)

A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data
por: Karlsson, Andreas, et al.
Publicado: (2019)

Lifestyle predictors for inconsistent participation to fecal based colorectal cancer screening
por: Knudsen, Markus Dines, et al.
Publicado: (2022)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Predictors of repeat participation in the NHS bowel cancer screening programme
por: Lo, S H, et al.
Publicado: (2015)

Thinking Style as a Predictor of Men’s Participation in Cancer Screening
por: McGuiness, Clare E., et al.
Publicado: (2016)

Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol
por: Musoro, Zebedee Jammbe, et al.
Publicado: (2018)

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
por: George, Gincy, et al.
Publicado: (2023)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
por: De Laere, Bram, et al.
Publicado: (2021)

Feasibility and Outcomes of an Internet-Based Mindfulness Training Program: A Pilot Randomized Controlled Trial
por: Kvillemo, Pia, et al.
Publicado: (2016)

Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta’s Tomorrow Project participants stratified by risk
por: Solbak, Nathan M., et al.
Publicado: (2018)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

Androgen deprivation therapy for prostate cancer and risk of dementia
por: Robinson, David, et al.
Publicado: (2019)

Risk perception after genetic counseling in patients with increased risk of cancer
por: Rantala, Johanna, et al.
Publicado: (2009)

Associations between Reoperations and Psychological Factors after Contralateral Risk-Reducing Mastectomy: A Two-Year Follow-Up Study
por: Unukovych, Dmytro, et al.
Publicado: (2016)

Risk of Prostate Cancer after Trans Urethral Resection of BPH: A Cohort and Nested Case-Control Study
por: Karlsson, Camilla T., et al.
Publicado: (2011)

Self-management challenges following hospital discharge for patients with multimorbidity: a longitudinal qualitative study of a motivational interviewing intervention
por: Brandberg, Carina, et al.
Publicado: (2021)

Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa
por: Mekuria, Legese A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f37qf8ji5c9pl3s8anat6g2ptq